Summary
Inovio Pharmaceuticals, Inc. (Inovio) is a biotechnology company. It undertakes the development of active DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on SynCon vaccine and electroporation delivery technologies. Inovio’s clinical programs are focused at treating leukemia, hepatitis C virus, cervical dysplasia, HIV and influenza. Inovio’s collaborators and partners include Merck, ChronTech, the University of Pennsylvania, University of Southampton, National Cancer Institute, NIH, HIV Vaccines Trial Network, U.S. Military HIV Research Program, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.
Inovio Pharmaceuticals, Inc. (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Inovio Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 11
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Inovio Pharma Acquires DNA Therapies For Alzheimer's Disease And Multiple Sclerosis From Fudan University 14
Partnerships 15
Inovio Pharma Enters into Research Agreement with Wistar Institute 15
GeneOne Life Science Enters into Research Agreement with Inovio Pharma 16
Inovio Pharma Enters into Co-Development Agreement with GeneOne Life Science 17
Path Malaria Vaccine Initiative And Inovio Pharma Partner To Accelerate Malaria Vaccine Development And Delivery Technologies 18
Inovio Pharma Amends Agreement With Path Malaria Vaccine Initiative For DNA Vaccine 20
Licensing Agreements 21
MedImmune Enters into Licensing Agreement with Inovio Pharma 21
Roche Terminates Licensing Agreement with Inovio Pharma for Prostate Cancer and Hepatitis B Immunotherapy Products 22
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 24
GeneOne Life Science Amends Licensing Agreement with Inovio Pharma 26
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 27
Inovio Pharma Enters Into Licensing Agreement With OncoSec Medical 29
GeneOne Life Science Enters into Licensing Agreement with Inovio Pharma 31
Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania 32
Equity Offering 33
Inovio Pharma Raises USD87.4 Million Public Offering of Shares 33
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 35
Inovio Pharma Completes Public Offering Of Common Stock And Warrants For US$15 Million 37
Inovio Pharma Completes Underwritten Public Offering Of Units For US$4 Million 39
Inovio Pharma Completes Private Placement Of US$3.8 Million 41
Inovio Pharma Completes An Underwritten Registered Offering For US$24 Million 43
Asset Transactions 45
Plumbline Life Sciences Acquires Animal Health Assets from VGX Animal Health 45
Inovio Pharmaceuticals, Inc. - Key Competitors 46
Key Employees 47
Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Tables
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Inovio Pharmaceuticals, Inc., Deals By Therapy Area, 2010 to YTD 2016 9
Inovio Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 11
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12
Inovio Pharma Acquires DNA Therapies For Alzheimer's Disease And Multiple Sclerosis From Fudan University 14
Inovio Pharma Enters into Research Agreement with Wistar Institute 15
GeneOne Life Science Enters into Research Agreement with Inovio Pharma 16
Inovio Pharma Enters into Co-Development Agreement with GeneOne Life Science 17
Path Malaria Vaccine Initiative And Inovio Pharma Partner To Accelerate Malaria Vaccine Development And Delivery Technologies 18
Inovio Pharma Amends Agreement With Path Malaria Vaccine Initiative For DNA Vaccine 20
MedImmune Enters into Licensing Agreement with Inovio Pharma 21
Roche Terminates Licensing Agreement with Inovio Pharma for Prostate Cancer and Hepatitis B Immunotherapy Products 22
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 24
GeneOne Life Science Amends Licensing Agreement with Inovio Pharma 26
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 27
Inovio Pharma Enters Into Licensing Agreement With OncoSec Medical 29
GeneOne Life Science Enters into Licensing Agreement with Inovio Pharma 31
Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania 32
Inovio Pharma Raises USD87.4 Million Public Offering of Shares 33
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 35
Inovio Pharma Completes Public Offering Of Common Stock And Warrants For US$15 Million 37
Inovio Pharma Completes Underwritten Public Offering Of Units For US$4 Million 39
Inovio Pharma Completes Private Placement Of US$3.8 Million 41
Inovio Pharma Completes An Underwritten Registered Offering For US$24 Million 43
Plumbline Life Sciences Acquires Animal Health Assets from VGX Animal Health 45
Inovio Pharmaceuticals, Inc., Key Competitors 46
Inovio Pharmaceuticals, Inc., Key Employees 47
Inovio Pharmaceuticals, Inc., Subsidiaries 48
List of Figures
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
Inovio Pharmaceuticals, Inc., Medical Devices Deals, 2010 to YTD 2016 11
